论文部分内容阅读
Background The therapeutic efficiency of bone marrow mononuclear cells (BMMNCs) autologous transplantation formyocardial infarction (MI) remains low.We developed a novel strategy to improve cardiac repair by preconditioning BMMNCs via angiotensin Ⅱ type 2 receptor (AT2R) stimulation.